Medifast, Inc.
General ticker "MED" information:
- Sector: Consumer Discretionary
- Industry: Personal Products & Services
- Capitalization: $156.2M (TTM average)
Medifast, Inc. does not follow the US Stock Market performance with the rate: -8.6%.
Estimated limits based on current volatility of 1.8%: low 11.69$, high 12.11$
Factors to consider:
- Total employees count: 504 as of 2024
- Top business risk factors: Market competition, Strategic risks and growth management, Third-party risks, Manufacturing disruptions, Key management loss
- Current price 16.0% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [12.34$, 21.70$]
- 2025-12-31 to 2026-12-31 estimated range: [14.08$, 23.95$]
Financial Metrics affecting the MED estimates:
- Positive: with PPE of 8.6 at the end of fiscal year the price was neutral
- Positive: -5.02 < Operating profit margin, % of 0.48
- Positive: 6.63 < Operating cash flow per share per price, % of 12.88
- Negative: Investing cash flow per share per price, % of -13.96 <= -4.41
- Negative: Return on assets ratio (scaled to [-100,100]) of 0.73 <= 1.77
Short-term MED quotes
Long-term MED plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,598.58MM | $1,072.05MM | $602.46MM |
| Operating Expenses | $1,413.77MM | $945.65MM | $599.59MM |
| Operating Income | $184.81MM | $126.40MM | $2.88MM |
| Non-Operating Income | $-0.75MM | $2.40MM | $0.91MM |
| Income(Loss) | $184.06MM | $128.80MM | $3.79MM |
| Taxes | $40.49MM | $29.38MM | $1.70MM |
| Profit(Loss)* | $143.57MM | $99.42MM | $2.09MM |
| Stockholders Equity | $155.04MM | $201.48MM | $210.11MM |
| Inventory | $118.86MM | $54.59MM | $42.42MM |
| Assets | $316.21MM | $309.91MM | $284.21MM |
| Operating Cash Flow | $194.57MM | $147.66MM | $24.48MM |
| Capital expenditure | $16.68MM | $6.48MM | $7.45MM |
| Investing Cash Flow | $-11.41MM | $-61.05MM | $-26.52MM |
| Financing Cash Flow | $-199.58MM | $-79.79MM | $-1.51MM |
| Earnings Per Share** | $12.82 | $9.13 | $0.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.